Associated Papers
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations.
Aleo SJ et al.
Human Molecular Genetics, 2021
33231680 (PubMed )
Supplement: supplementary_material_19-10-20_ddaa244.docx
OPA1-associated disorders: phenotypes and pathophysiology.
Amati-Bonneau P et al.
The International Journal of Biochemistry & Cell Biology, 2009
Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.
Davies VJ et al.
Human Molecular Genetics, 2007
OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.
Pesch UE et al.
Human Molecular Genetics, 2001
Select a paper to view details